• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pfizer, BioNTech Enter Vax Pact with COVAX

    FDA Approves Janssen’s CABENUVA

    AGC Biologics Appoints Boulder Site GM

    Lilly Completes $1B Acquisition of Prevail

    Top BioPharma Form Accumulus Synergy
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Integrated Continuous Manufacturing ICM

    CONTINUUS Awarded $69.3M DoD Grant

    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Lilly Completes $1B Acquisition of Prevail

    Top BioPharma Form Accumulus Synergy

    Coating Place Wurster Fluid Bed Process Scaling

    AbbVie Licenses ProBioGen’s GlymaxX Technology

    Improving Product Profitability
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Reed-Lane

    Aphena Pharma Solutions

    Adare Pharma Solutions

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Cytovance Biologics

    Alcami

    Aphena Pharma Solutions

    Almac Group

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    The acquisition deal includes Acorda Therapeutics’ 90,000 square-foot, FDA-inspected CGMP facility in Chelsea, MA.
    Related CONTENT
    • Pfizer, BioNTech Enter Vax Pact with COVAX
    • AGC Biologics Appoints Boulder Site GM
    • Eisai Appoints Chief Clinical Officer of Oncology Biz
    • Valeo Pharma Appoints President, COO
    • Janssen, TenNor Enter NTM Research Pact
    Contract Pharma Staff01.13.21
    Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has entered into an agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics, a developer of therapies to restore function and improve the lives of people with neurological disorders. The acquisition complements Catalent’s status as a premier U.S.-based partner for companies across dry powder inhaled dose forms. Completion of the deal is expected to occur in the first quarter of this year.
     
    Under the terms of the agreement, Catalent will acquire Acorda Therapeutics’ 90,000 square-foot, FDA-inspected CGMP facility in Chelsea, MA, close to Boston Logan International Airport and the thriving biotechnology networks centered around Boston and Cambridge. The site operates best-in-class spray drying capacity, including GEA NIRO PSD-1, PSD-4 and PSD-7 spray drying units, with the latter unit being the largest equipment of its kind in North America, and will provide Catalent with significant commercial-scale capacity for new customer programs. The facility will act as a global center of excellence within the Catalent network for spray-dried dispersion and dry powder encapsulation and packaging. On closing, Acorda Therapeutics’ current workforce at the facility will transition employment to Catalent.
     
    Catalent has also entered into a long-term supply agreement with Acorda Therapeutics to continue commercial manufacture of INBRIJA (levodopa inhalation powder) from the Chelsea facility. INBRIJA is a prescription medicine from Acorda Therapeutics indicated for use when needed with hypomobility or OFF episodes in adults with Parkinson’s disease treated with regular carbidopa/levodopa medicine.
     
    "Catalent is a premier partner to companies working on multiple forms of inhaled drug delivery, from early-stage development to commercial-scale supply," said Jonathan Arnold, president of oral and specialty delivery, Catalent. “This acquisition complements our existing U.S.-based capabilities in metered-dose and nasal inhalation by adding an experienced team of people and a premier facility enabling us to provide customers with extended capabilities for commercial-scale filling and packaging of dry powder inhalers.”
     
    The Chelsea site will complement and provide downstream capabilities to Catalent’s 180,000 square-foot inhalation development facility in Morrisville, Research Triangle Park, NC, which includes development and manufacturing for metered dose inhalers, nasal sprays, and dry powder inhalers. The Morrisville site offers high-speed commercial-scale manufacturing as well as flexible fill lines for clinical-scale and small batch production.
    Related Searches
    • Drug Delivery
    Suggested For You
    Pfizer, BioNTech Enter Vax Pact with COVAX  Pfizer, BioNTech Enter Vax Pact with COVAX
    AGC Biologics Appoints Boulder Site GM AGC Biologics Appoints Boulder Site GM
    Eisai Appoints Chief Clinical Officer of Oncology Biz  Eisai Appoints Chief Clinical Officer of Oncology Biz
    Valeo Pharma Appoints President, COO Valeo Pharma Appoints President, COO
    Janssen, TenNor Enter NTM Research Pact Janssen, TenNor Enter NTM Research Pact
    Biologics Development & Manufacturing Biologics Development & Manufacturing
    Cognate BioServices Announces Major Expansion Cognate BioServices Announces Major Expansion
    Bioclinica Partners with Ikcon Pharma Bioclinica Partners with Ikcon Pharma
    Thermo Fisher Buys Novasep Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Charles River Partners with JADE Charles River Partners with JADE
    Cytiva Delivers Modular Biologics Factory to Lonza Cytiva Delivers Modular Biologics Factory to Lonza
    RheinCell Therapeutics Achieves GMP Certification RheinCell Therapeutics Achieves GMP Certification
    Capricor, Lonza Enter CAP-1002 Development Agreement Capricor, Lonza Enter CAP-1002 Development Agreement
    Drug Product Development, Manufacturing, and Packaging Drug Product Development, Manufacturing, and Packaging
    Northway Biotech Expands to the US: Boston Facility Grand Opening Northway Biotech Expands to the US: Boston Facility Grand Opening

    Related Breaking News

    • Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
      iosBio Inks Exclusive Vax Platform Pact for COVID-19

      iosBio Inks Exclusive Vax Platform Pact for COVID-19

      OraPro oral delivery vaccine platform technology enables oral administration of thermally-stable, viral vector vaccines.
      Contract Pharma Staff 01.12.21

    • Breaking News | Cytotoxics and High Potency Manufacturing | Drug Delivery | Facilities | Industry News
      Inhalation CDMO Vectura Expands HPAPI Capabilities

      Inhalation CDMO Vectura Expands HPAPI Capabilities

      New facility will increase containment operations at Chippenham, UK site.
      Contract Pharma Staff 12.14.20

    • Drug Delivery | Industry News
      Recipharm, Medspray Establish JV

      Recipharm, Medspray Establish JV

      To exploit novel softmist technology for pharmaceutical applications.
      Contract Pharma Staff 11.17.20


    • Breaking News | Drug Delivery | Drug Development | Industry News
      Novo Nordisk to Acquire Emisphere Technologies

      Novo Nordisk to Acquire Emisphere Technologies

      Gains the Eligen SNAC oral delivery technology.
      Contract Pharma Staff 11.13.20

    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Parenterals
      Ypsomed Collaborates with Schott and Lonza

      Ypsomed Collaborates with Schott and Lonza

      Aims to deliver a comprehensive solution for wearable patch injectors.
      Contract Pharma Staff 11.10.20

    • Drug Delivery | Drug Development | Trials & Filings
      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Leverages the company’s Precision Olfactory Delivery technology
      11.09.20


    • Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
      HHS Funds Development of Needle-free Vax Technology

      HHS Funds Development of Needle-free Vax Technology

      Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.
      Contract Pharma Staff 10.07.20

    • Breaking News | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
      Evonik Launches New Oral Drug Delivery Technology

      Evonik Launches New Oral Drug Delivery Technology

      For enteric protection and rapid release in the upper small intestine.
      Contract Pharma Staff 10.06.20

    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
      Stevanato Group and Bexson Biomedical Collaborate

      Stevanato Group and Bexson Biomedical Collaborate

      Will develop a wearable drug delivery device for Bexson’s proprietary ketamine formulation.
      Contract Pharma Staff 09.22.20


    • Breaking News | Drug Delivery | Industry News
      Lubrizol Supports Women’s Health Worldwide

      Lubrizol Supports Women’s Health Worldwide

      Awarded grant for generic contraceptive injection research to advance women’s health around the globe.
      Contract Pharma Staff 09.16.20

    • Breaking News | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
      Colorcon Launches Acryl-EZE II

      Colorcon Launches Acryl-EZE II

      Extends pH range of enteric coatings for pharmaceutical use.
      Contract Pharma Staff 07.17.20

    • Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
      Vectura Signs Agreement with Aerami Therapeutics

      Vectura Signs Agreement with Aerami Therapeutics

      Will support the development of imatinib for the treatment of Pulmonary Arterial Hypertension
      Contract Pharma Staff 06.08.20


    • Bio News | Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
      Virpax Completes pre-IND Meeting with FDA

      Virpax Completes pre-IND Meeting with FDA

      Epoladerm spray being developed with contract service company MedPharm
      Contract Pharma Staff 05.22.20

    • Breaking News | Drug Delivery | Industry News
      Kindeva Launches as an Independent Company

      Kindeva Launches as an Independent Company

      Was formerly known as 3M Drug Delivery Systems
      Contract Pharma Staff 05.04.20

    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Injectables | Packaging & Tracking
      Stevanato Group Collaborates with Cambridge Design Partnership

      Stevanato Group Collaborates with Cambridge Design Partnership

      The companies will develop a pen-injector for patients suffering from diabetes together.
      Contact Pharma Staff 04.28.20

    Trending
    • Integrated Continuous Manufacturing ICM
    • Pfizer, BioNTech Enter Vax Pact With COVAX
    • CONTINUUS Awarded $69.3M DoD Grant
    • Piramal Inks Clinical Supply Deal With Theratechnologies
    • AbbVie Licenses ProBioGen’s GlymaxX Technology
    Breaking News
    • Pfizer, BioNTech Enter Vax Pact with COVAX
    • FDA Approves Janssen’s CABENUVA
    • AGC Biologics Appoints Boulder Site GM
    • Lilly Completes $1B Acquisition of Prevail
    • Top BioPharma Form Accumulus Synergy
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    LINE-X Launches Dealer Program with International Truck
    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Carol’s Daughter Adds New Hair Products
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login